The purpose of this American Gastroenterological Association (AGA) Institute Clinical Practice Update (CPU) is to review the available evidence and provide expert advice regarding diagnosis and management of cannabinoid hyperemesis syndrome. This CPU was commissioned and approved by the AGA Institute Clinical Practice Updates Committee (CPUC) and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership and underwent internal peer review by the CPUC and external peer review through standard procedures of This expert commentary incorporates important as well as recently published studies in this field, and it reflects the experiences of the authors.

中文翻译：

---

AGA 关于大麻素剧吐综合征诊断和治疗的临床实践更新：评论

美国胃肠病学协会 (AGA) 研究所临床实践更新 (CPU) 的目的是审查现有证据并提供有关大麻素剧吐综合征的诊断和治疗的专家建议。该 CPU 是由 AGA 研究所临床实践更新委员会 (CPUC) 和 AGA 理事会委托并批准的，旨在就对 AGA 会员具有高度临床重要性的主题提供及时指导，并接受了 CPUC 的内部同行评审和通过以下方式进行的外部同行评审：本专家评论纳入了该领域的重要研究和最近发表的研究，反映了作者的经验。